Choice Switching and Autism

Sponsor
Technion, Israel Institute of Technology (Other)
Overall Status
Completed
CT.gov ID
NCT04631432
Collaborator
(none)
114
1
8.4
13.6

Study Details

Study Description

Brief Summary

The study aims to replicate and clarify a recently observed phenomenon whereby individuals with Autism Spectrum Disorder (ASD) switch between options in a repeated task to a greater extent than healthy controls do. In a meta-analysis a large effect size was found (.37) yet because the effect was noisy in different studies it was not statistically significant. The investigators seek to first examine a very large population through an Internet mediated platform. The sample size will be about the size of all of the previous studies that examined this issue together. Secondly, the investigators wish to understand the discrepancy between this choice switching phenomenon and the recorded tendency of ASD individuals to avoid changing choices. First, the investigators will administer the task in which the effect was found (the Iowa Gambling task) for a longer duration than previously and evaluate whether ASD individuals show increased choice switching in the first blocks of trials but reduced switching following more experience. Secondly, the investigators will administer an additional block of trials without feedback in which participants will not be able to go through a learning process. The investigators predict that this will reduce (and possible flip) the tendency of individuals with ASD to switch choices more often.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Pre-screening
  • Behavioral: Task session

Study Design

Study Type:
Observational
Actual Enrollment :
114 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Choice Switching and Autism
Actual Study Start Date :
Jan 1, 2021
Actual Primary Completion Date :
Aug 13, 2021
Actual Study Completion Date :
Sep 13, 2021

Arms and Interventions

Arm Intervention/Treatment
Study participation

All participants will complete the same protocol

Diagnostic Test: Pre-screening
Document upload of Autism diagnosis certificate. Participants can request to show their certificate via a Zoom meeting with the researcher instead of uploading it.

Behavioral: Task session
The Iowa Gambling task- four decks of cards on the computer screen. Each card yields a reward, but might also yield a loss. In each trial, the participant selects a card. Consequently, the card is exposed, displaying the gain and the loss for that trial. Through contingent feedback, participants are expected to learn that some deck are better than others.The task will include 120 trials. Block of trials without feedback- four decks of cards on the computer screen. Each card yields a reward, but might also yield a loss. In each trial, the participant selects a card. Consequently, the card is exposed, but the gain and the loss for that trial are not displayed. The task will include 30 trials. Social Responsiveness Scale, 2nd Edition (SRS-2; adult-self report):(Constantino & Gruber, 2012) The brief autism quotient scale:(AQ10; Baron-Cohen et al., 2001) Brief intelligence test (Similarities-MAB + Raven Set 1)

Outcome Measures

Primary Outcome Measures

  1. Mean run size [Through study completion, an average of 1 year]

    Number of consecutive selections from the same deck (across trials and in different blocks).

  2. Advantageous selections [Through study completion, an average of 1 year]

    Percentage of advantageous selections(across trials and in different blocks).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ASD group - Diagnosed with ASD

  • Control - No ASD diagnosis: within age and education range of the ASD group.

Exclusion Criteria:
  • Demographics: Under 18 years of age.

  • Mental health: self reported brain injury and neurological disorder (besides autism).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Technion, Israel Institute of Technology Haifa Israel

Sponsors and Collaborators

  • Technion, Israel Institute of Technology

Investigators

  • Study Director: Dana Zeif, MSc, Technion, Israel Institute of Technology
  • Study Director: Ofir Yakobi, PhD, University of Waterloo
  • Principal Investigator: Eldad Yechaim, Professor, Technion, Israel Institute of Technology

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Prof. Eldad Yechiam, Professor, Technion, Israel Institute of Technology
ClinicalTrials.gov Identifier:
NCT04631432
Other Study ID Numbers:
  • 109171
  • Technion institute 109171
First Posted:
Nov 17, 2020
Last Update Posted:
Apr 27, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Prof. Eldad Yechiam, Professor, Technion, Israel Institute of Technology
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 27, 2022